Aptevo Therapeutics Inc. Contracts & Agreements

133 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Placement Agency Agreement, dated April 21, 2025, between the Company and Roth Capital Partners
Agency Agreements
Aptevo Therapeutics Inc.
Biotechnology
2025
Form of Securities Purchase Agreement, dated April 21, 2025, between the Company and the purchasers party thereto
Aptevo Therapeutics Inc.
Biotechnology
2025
Form of Common Warrant, dated April 4, 2025
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2025
Form of Amended Common Warrant, dated April 4, 2025 (originally entered into on December 12, 2024), between the Company and certain warrant holders
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2025
Form of Placement Agency Agreement, dated April 3, 2025, between the Company and Roth Capital Partners
Agency Agreements
Aptevo Therapeutics Inc.
Biotechnology
2025
Form of Securities Purchase Agreement, dated April 3, 2025, between the Company and the purchasers party thereto
Purchase Agreements
Aptevo Therapeutics Inc.
Biotechnology
2025
Form of Series B Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2025
Form of Series B Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2025
Form of Pre-Funded Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2025
Form of Series A Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2025
Form of Series B Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2025
Form of Securities Purchase Agreement
Purchase Agreements
Aptevo Therapeutics Inc.
Biotechnology
2025
Form of Placement Agency Agreement
Agency Agreements
Aptevo Therapeutics Inc.
Biotechnology
2025
Form of Pre-Funded Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2025
Form of Common Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2025
Form of Securities Purchase Agreement
Purchase Agreements
Aptevo Therapeutics Inc.
Biotechnology
2025
Form of Placement Agency Agreement
Agency Agreements
Aptevo Therapeutics Inc.
Biotechnology
2025
Form of Common Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Form of Warrant Inducement Agreement, by and between the Company and each Holder
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2024
Amendment No. 4 to Rights Agreement, dated as of November 1, 2024, between the Company and Broadridge Corporate Issuer Solution, Inc., as Rights Agent
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Common Warrant, dated September 18, 2024
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Pre-funded Warrant, dated September 18, 2024
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Placement Agency Agreement, dated September 16, 2024, between the Company and Roth Capital Partners
Agency Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Securities Purchase Agreement, dated September 16, 2024, between the Company and the purchasers party thereto
Purchase Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Form of Amended Series A-1 Common Warrant, dated September 18, 2024 (originally entered into on November 9, 2023), between the Company and certain warrant holders
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2024
Form of Amended Series A-2 Common Warrant, dated September 18, 2024 (originally entered into on November 9, 2023), between the Company and certain warrant holders
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2024
Form of Amended Series B-1 Common Warrant, dated September 18, 2024 (originally entered into on November 9, 2023), between the Company and certain warrant holders
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2024
Form of Amended Series B-2 Common Warrant, dated September 18, 2024 (originally entered into on November 9, 2023), between the Company and certain warrant holders
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2024
Form of Amended Warrant, dated September 18, 2024 (originally entered into on April 15, 2024), between the Company and certain warrant holders
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Form of Amended Warrant, dated September 18, 2024 (originally entered into on July 1, 2024), between the Company and certain warrant holders
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Form of Pre-Funded Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Form of Common Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
PLACEMENT AGENCY AGREEMENT
Agency Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Common Warrant, dated July 1, 2024
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Pre-Funded Warrant, dated July 1, 2024
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Placement Agency Agreement dated June 28, 2024, between the Company and Roth Capital Partners
Agency Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Securities Purchase Agreement, dated June 28, 2024, between the Company and the purchasers party thereto
Purchase Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Form of Amended Common Warrant, dated as of July 1, 2024, between the Company and certain warrant holders
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Form of Amended Series A Common Warrant, dated as of July 1, 2024, between the Company and certain warrant holders
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2024
Form of Amended Series A-1 Common Warrant, dated as of July 1, 2024, between the Company and certain warrant holders
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2024
Form of Amended Series A-2 Common Warrant, dated as of July 1, 2024, between the Company and certain warrant holders
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2024
Form of Amended Series B-1 Common Warrant, dated as of July 1, 2024, between the Company and certain warrant holders
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2024
Form of Amended Series B-2 Common Warrant, dated as of July 1, 2024, between the Company and certain warrant holders
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2024
Form of Pre-Funded Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Form of Common Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Form of Securities Purchase Agreement
Purchase Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Form of Placement Agency Agreement
Agency Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Common Warrant, dated April 15, 2024
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Pre-funded Warrant, dated April 15, 2024
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Placement Agent Agreement, dated April 10, 2024, between the Company and Roth Capital Partners
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Securities Purchase Agreement, dated April 10, 2024, between the Company and the purchasers party thereto
Purchase Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Form of Pre-Funded Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Form of Common Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Form of Securities Purchase Agreement
Purchase Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Form of Placement Agency Agreement
Agency Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2024
Form of New Series A-1 Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2023
Form of New Series A-2 Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2023
Form of New Series B-1 Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2023
Form of New Series B-2 Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2023
Form of Warrant Inducement Agreement, by and between the Company and each Holder
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2023
Financial Advisory Agreement, dated as of November 9, 2023, between A.G.P./Alliance Global Partners and the Company
Advisory Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2023
Amendment No. 3 to Rights Agreement, dated as of November 2, 2023, between the Company and Broadridge Corporate Issuer Solution, Inc., as Rights Agent
Aptevo Therapeutics Inc.
Biotechnology
NY
2023
Series A Common Warrant, dated August 4, 2023
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2023
Series B Common Warrant, dated August 4, 2023
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2023
Pre-funded Warrant, dated August 4, 2023
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2023
Placement Agent Agreement, dated August 1, 2023, between the Company and A.G.P./Alliance Global Partners
Aptevo Therapeutics Inc.
Biotechnology
NY
2023
Securities Purchase Agreement, dated August 1, 2023, between the Company and the purchasers party thereto
Purchase Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2023
Form of Placement Agent Agreement
Aptevo Therapeutics Inc.
Biotechnology
NY
2023
Form of Pre-Funded Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2023
Form of Common Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
2023
Form of Securities Purchase Agreement
Purchase Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2023
Third Amendment to Credit and Security Agreement dated August 30, 2022
Credit Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2022
Amendment No. 2 to Rights Agreement, dated as of November 4, 2022, between the Company and Broadridge Corporate Issuer Solutions, Inc., as Rights Agent
Aptevo Therapeutics Inc.
Biotechnology
NY
2022
Amendment to Royalty Purchase Agreement dated June 7, 2022
Purchase Agreements
Aptevo Therapeutics Inc.
Biotechnology
2022
Limited Consent and Second Amendment to Credit and Security Agreement dated June 7, 2022
Credit Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2022
Ninth Amendment to Office Lease, dated May 26, 2022, by and between Aptevo Therapeutics Inc. and Selig Real Estate Holdings Eight L.L.C
Lease Agreements
Aptevo Therapeutics Inc.
Biotechnology
2022
Agreement to Terminate Registration Rights Agreement between the Company and Intervac L.L.C. and BioVac L.L.C
Registration Rights Agreements
Aptevo Therapeutics Inc.
Biotechnology
DE
2022
Aptevo Therapeutics Inc. Amended and Restated Senior Management Severance Plan
Severance Agreements
Aptevo Therapeutics Inc.
Biotechnology
DE
2022
Purchase Agreement, dated February 16, 2022, by and between the Company and Lincoln Park
Purchase Agreements
Aptevo Therapeutics Inc.
Biotechnology
DE
2022
Registration Rights Agreement, dated February 16, 2022, by and between the Company and Lincoln Park
Registration Rights Agreements
Aptevo Therapeutics Inc.
Biotechnology
DE
2022
Executive Transition Services Agreement
Transition Agreements
Aptevo Therapeutics Inc.
Biotechnology
2021
Amendment to Executive Transition Services Agreement
Transition Agreements
Aptevo Therapeutics Inc.
Biotechnology
2021
Amendment No. 1 to Rights Agreement, dated as of November 5, 2021, between the Company and Broadridge Corporate Issuer Solutions, Inc., as Rights Agent
Aptevo Therapeutics Inc.
Biotechnology
2021
Royalty Purchase Agreement by and among Aptevo Therapeutics Inc. and Healthcare Royalty Partners IV, LP. dated as of March 30, 2021
Purchase Agreements
Aptevo Therapeutics Inc.
Biotechnology
DE
2021
Description of Capital Stock of Aptevo Therapeutics
Stock Agreements
Aptevo Therapeutics Inc.
Biotechnology
2021
Equity Distribution Agreement, dated December 14, 2020, between Aptevo Therapeutics Inc. and Piper Sandler & Co
Equity Distribution Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2020
Rights Agreement, dated as of November 8, 2020, by and between Aptevo Therapeutics Inc. and Broadridge Corporate Issuer Solutions, Inc., as rights agent
Registration Rights Agreements
Aptevo Therapeutics Inc.
Biotechnology
DE
2020
Collaboration and License Agreement, dated as of December 19, 2005, by and among Wyeth Pharmaceuticals and Trubion Pharmaceuticals, Inc
Collaboration Agreements
Aptevo Therapeutics Inc.
Biotechnology
WA
2020
Amendment No. 1 to the Collaboration and License Agreement dated as of December 19, 2005 (the Agreement) by and between Trubion Pharmaceuticals, Inc. (Trubion) and Wyeth, acting...
Collaboration Agreements
Aptevo Therapeutics Inc.
Biotechnology
2020
Amendment No. 2 to the Collaboration and License Agreement dated as of December 19, 2005 (as previously amended, the Agreement) by and between Trubion Pharmaceuticals, Inc....
Collaboration Agreements
Aptevo Therapeutics Inc.
Biotechnology
2020
Amendment No. 3 to the Collaboration and License Agreement dated as of December 19, 2005 (as previously amended, the Agreement) by and between Emergent Product Development...
Collaboration Agreements
Aptevo Therapeutics Inc.
Biotechnology
2020
Amendment No. 4 to the Collaboration and License Agreement dated as of December 19, 2005 (as previously amended, the Agreement) by and between Emergent Product Development...
Collaboration Agreements
Aptevo Therapeutics Inc.
Biotechnology
2020
LLC Purchase Agreement by and among Aptevo Therapeutics Inc. and Medexus Pharma, Inc. dated February 28, 2020
Purchase Agreements
Aptevo Therapeutics Inc.
Biotechnology
DE
2020
Amendment to Lease Dated April 28, 2003 by and between Selig Real Estate Holdings Eight, LLC and later assigned to SREH 2018 Holdings LLC and Aptevo Research and Development LLC
Lease Agreements
Aptevo Therapeutics Inc.
Biotechnology
2019
Amendment to LLC Purchase Agreement, dated as of August 31, 2017, by and among Aptevo BioTherapeutics LLC, Aptevo Therapeutics Inc., Venus Bio Therapeutics Sub LLC, and Saol...
Purchase Agreements
Aptevo Therapeutics Inc.
Biotechnology
2019
Eighth Amendment to Office Lease, dated as of March 19, 2019, by and between Aptevo Therapeutics Inc. and Selig Real Estate Holdings Eight L.L.C
Lease Agreements
Aptevo Therapeutics Inc.
Biotechnology
2019
Amendment No. 1 to Amended and Restated Credit and Security Agreement, dated December 14, 2018, by and among, Aptevo Therapeutics Inc., Aptevo Biotherapeutics LLC, Aptevo Research...
Credit Agreements
Aptevo Therapeutics Inc.
Biotechnology
2019
Intellectual Property Security Agreement, dated February 7, 2019, by and amoung, Aptevo Therapeutics Inc., Aptevo Biotherapeutics LLC., Aptevo Research and Development, LLC and...
Security Agreements
Aptevo Therapeutics Inc.
Biotechnology
2019
Underwriting Agreement between Aptevo Therapeutics, Inc. and Piper Jaffray & Co., dated March 7, 2019
Underwriting Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2019
Form of Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2019
Form of Pre-Funded Warrant
Warrant Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2019
Purchase Agreement between Aptevo Therapeutics Inc. and Lincoln Park Capital Fund, LLC, dated December 20, 2018
Purchase Agreements
Aptevo Therapeutics Inc.
Biotechnology
IL
2018
Registration Rights Agreement between Aptevo Therapeutics Inc. and Lincoln Park Capital Fund, LLC, dated December 20, 2018
Registration Rights Agreements
Aptevo Therapeutics Inc.
Biotechnology
IL
2018
Aptevo Therapeutics Inc. 2018 Stock Incentive Plan
Bonus & Incentive Agreements
Aptevo Therapeutics Inc.
Biotechnology
DE
2018
Aptevo Therapeutics Inc. Non-Statutory Stock Option Agreement
Stock Agreements
Aptevo Therapeutics Inc.
Biotechnology
2018
Amended and Restated Manufacturing Services Agreement, dated September 28, 2017, by and between Emergent BioSolutions Inc. and Aptevo Therapeutics Inc
Services Agreements
Aptevo Therapeutics Inc.
Biotechnology
2018
Amended and Restated Trademark License Agreement, dated September 28, 2017, by and between Emergent BioSolutions Inc. and Aptevo Therapeutics Inc
Trademark Agreements
Aptevo Therapeutics Inc.
Biotechnology
2018
Amendment No. 3 to Credit and Security Agreement, dated as of February 23, 2018, by and among Aptevo Therapeutics Inc. and certain of its subsidiaries and Midcap Financial Trust
Credit Agreements
Aptevo Therapeutics Inc.
Biotechnology
2018
LLC Purchase Agreement, dated as of August 31, 2017, by and among Aptevo BioTherapeutics LLC, Aptevo Therapeutics Inc., Venus Bio Therapeutics Sub LLC, and Saol International...
Purchase Agreements
Aptevo Therapeutics Inc.
Biotechnology
DE
2017
Collaboration and Option Agreement, dated as of July 20, 2017, by and between Aptevo Research and Development LLC, and Alligator Bioscience AB
Collaboration Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2017
Equity Distribution Agreement, dated November 9, 2017, between Aptevo Therapeutics Inc. and Piper Jaffray and Company, LLC
Equity Distribution Agreements
Aptevo Therapeutics Inc.
Biotechnology
NY
2017
Amendment No. 2 to Credit and Security Agreement dated September 28, 2017
Credit Agreements
Aptevo Therapeutics Inc.
Biotechnology
2017
APTEVO THERAPEUTICS INC. 2016 STOCK INCENTIVE PLAN
Bonus & Incentive Agreements
Aptevo Therapeutics Inc.
Biotechnology
DE
2017
Amended and Restated COMMERCIAL SUPPLY AGREEMENT BETWEEN CMC ICOS BIOLOGICS, INC. and APTEVO BIOTHERAPEUTICS LLC. DISCLAIMER THIS DOCUMENT IS ISSUED BY CMC FOR DISCUSSION PURPOSES...
Supply Agreements
Aptevo Therapeutics Inc.
Biotechnology
DE
2017
FOURTH AMENDMENT TO LICENSE AND CO-DEVELOPMENT AGREEMENT
License Agreements
Aptevo Therapeutics Inc.
Biotechnology
2017
amendment No. 1 to CREDIT AND SECURITY AGREEMENT
Credit Agreements
Aptevo Therapeutics Inc.
Biotechnology
2017
THIRD AMENDMENT TO LICENSE AND CO-DEVELOPMENT AGREEMENT
License Agreements
Aptevo Therapeutics Inc.
Biotechnology
2016
CONTRIBUTION AGREEMENT
Contribution Agreements
Aptevo Therapeutics Inc.
Biotechnology
DE
2016
SEPARATION AND DISTRIBUTION AGREEMENT BY AND BETWEEN EMERGENT BIOSOLUTIONS INC. AND APTEVO THERAPEUTICS INC. DATED AS OF JULY 29, 2016
Separation Agreements
Aptevo Therapeutics Inc.
Biotechnology
DE
2016
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Aptevo Therapeutics Inc.
Biotechnology
DE
2016
NON-NEGOTIABLE PROMISSORY NOTE
Note Agreements
Aptevo Therapeutics Inc.
Biotechnology
2016
TRANSITION SERVICES AGREEMENT BY AND BETWEEN EMERGENT BIOSOLUTIONS INC. AND APTEVO THERAPEUTICS INC. DATED AS OF JULY 29, 2016 TABLE OF CONTENTS
Transition Agreements
Aptevo Therapeutics Inc.
Biotechnology
2016
TAX MATTERS AGREEMENT
Aptevo Therapeutics Inc.
Biotechnology
DE
2016
EMPLOYEE MATTERS AGREEMENT BY AND BETWEEN EMERGENT BIOSOLUTIONS INC. AND APTEVO THERAPEUTICS INC. DATED AS OF JULY 29, 2016 TABLE OF CONTENTS
Aptevo Therapeutics Inc.
Biotechnology
2016
MANUFACTURING SERVICES AGREEMENT BY AND BETWEEN EMERGENT BIOSOLUTIONS INC. AND APTEVO THERAPEUTICS INC. DATED AS OF JULY 29, 2016 TABLE OF CONTENTS
Services Agreements
Aptevo Therapeutics Inc.
Biotechnology
2016
CANADIAN DISTRIBUTOR AGREEMENT BY AND BETWEEN EMERGENT BIOSOLUTIONS INC. AND APTEVO THERAPEUTICS INC. DATED AS OF JULY 29, 2016 TABLE OF CONTENTS
Aptevo Therapeutics Inc.
Biotechnology
2016
TRADEMARK LICENSE AGREEMENT BY AND BETWEEN EMERGENT BIOSOLUTIONS INC. AND APTEVO THERAPEUTICS INC. DATED AS OF JULY 29, 2016 TRADEMARK LICENSE AGREEMENT
Trademark Agreements
Aptevo Therapeutics Inc.
Biotechnology
2016
PRODUCT LICENSE AGREEMENT BY AND BETWEEN EMERGENT BIOSOLUTIONS INC. AND APTEVO THERAPEUTICS INC. DATED AS OF JULY 29, 2016 PRODUCT LICENSE AGREEMENT
License Agreements
Aptevo Therapeutics Inc.
Biotechnology
2016
APTEVO THERAPEUTICS INC. 2016 STOCK INCENTIVE PLAN
Bonus & Incentive Agreements
Aptevo Therapeutics Inc.
Biotechnology
DE
2016
APTEVO THERAPEUTICS INC. CONVERTED EQUITY AWARDS INCENTIVE PLAN
Bonus & Incentive Agreements
Aptevo Therapeutics Inc.
Biotechnology
DE
2016
Ke to Aptevo Therapeutics Inc. Senior Management Severance Plan
Severance Agreements
Aptevo Therapeutics Inc.
Biotechnology
DE
2016
FORM OF INDEMNITY AGREEMENT
Aptevo Therapeutics Inc.
Biotechnology
DE
2016